Clinical Trials Logo
  1. Home
  2. Ascites Hepatic
  3. NCT04384523

A Study of OsrHSA in Adult Healthy Male and Female Volunteers

Ascites Hepatic Clinical Trial

Official title:
A Phase 1 Randomized, Double Blinded, Placebo-Controlled Single Dose Escalation Study of OsrHSA in Adult Healthy Male and Female Volunteers

Clinical Trial Summary

A Phase 1 randomized, double blinded, placebo-controlled single dose escalation study of OsrHSA in adult healthy male and female volunteers

Clinical Trial Description

This is a Phase 1 randomized, double blinded, placebo-controlled, single dose escalation study to evaluate safety, tolerability, PK, and immunogenicity of OsrHSA in healthy volunteers. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04384523
Study type Interventional
Source Healthgen Biotechnology Corp.
Contact
Status Completed
Phase Phase 1
Start date November 4, 2019
Completion date July 13, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05014594 - Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT Phase 2
Recruiting NCT05793983 - S100A8/A9 and Innate Immunity in Liver Disease
Recruiting NCT05928624 - A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients N/A
Recruiting NCT04221672 - The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy Phase 3
Recruiting NCT05346393 - HRS-AKI Treatment With TIPS in Patients With Cirrhosis N/A
Recruiting NCT04322201 - Continuous Passive Paracentesis for Intra-abdominal Hypertension N/A
Completed NCT05013502 - Empagliflozin in Diuretic Refractory Ascites Phase 1
Withdrawn NCT04109144 - Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis Phase 2
Recruiting NCT05726747 - QOL and Sarcopenia in Patients With Ascites
Completed NCT04569565 - Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites N/A
Completed NCT03459378 - Outcome After TIPS
Recruiting NCT06256432 - Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Phase 2
Recruiting NCT05999773 - SGLT-2 Inhibitors in the Treatment of Ascites
Completed NCT03107091 - Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites Phase 2
Terminated NCT05765253 - Achieving Portal Access With Scorpion Post-Approval Study (APASS) N/A
Recruiting NCT05960006 - A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis
Completed NCT03191851 - Evaluation of 'Melody' Paracentesis Device for Ascites Therapy N/A
Recruiting NCT05490888 - Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics Phase 1
Not yet recruiting NCT06224023 - Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Terminated NCT03027635 - PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis N/A